Today: 19 July 2026
AppLovin stock dives 16% as AI ad-tech fears flare ahead of earnings
4 February 2026
2 mins read

AppLovin stock dives 16% as AI ad-tech fears flare ahead of earnings

New York, Feb 4, 2026, 4:38 PM ET — After-hours

  • AppLovin shares dropped 16.1% to $387.34 but held steady in after-hours trading
  • A report on AI startup CloudX shook mobile ad-tech stocks, dragging down AppLovin and Unity
  • Investors are shifting focus to the Feb. 11 earnings, seeking clues on competition and advertising demand

Shares of AppLovin Corp dropped 16.1% on Wednesday, slipping to $387.34 by the close—a $74.35 decline—after hitting an intraday low of $382.50. The stock showed little movement in after-hours trading as investors dumped mobile ad-tech names amid renewed concerns that new AI tools might disrupt the industry’s “ad stack.”

The decline comes just a week ahead of AppLovin’s earnings report, where the company must prove growth and margins can withstand automation encroaching on areas once seen as safe. It also highlights how fast “AI disruption” has shifted from hype to a trigger for selling pressure.

The trigger came from a report on startup CloudX, highlighted by AdExchanger as having reached general availability for a platform designed to “rewire the mobile ad stack using AI agents.” This software targets automating parts of the advertising process—deciding which ad appears, to whom, and at what price. According to the report, CloudX, led by CEO and co-founder Jim Payne, employs large language model agents—AI trained on vast text datasets—to replace tasks usually done by engineers and ad-ops teams. Unity Software shares dropped roughly 10%. Investing.com

The broader market added to the pressure. The Nasdaq Composite dropped 1.5% on Wednesday, weighed down by tech shares, while the Dow inched up 0.5%. Outside of big tech, many stocks managed to hold steady.

Investors worldwide are shifting away from software and growth stocks amid concerns that emerging AI technologies might disrupt established business models, Reuters reported. Meanwhile, the dollar strengthened following mixed U.S. economic data.

Some analysts say the market might be jumping the gun. Jefferies analyst Brent Thill dismissed worries around Google’s Project Genie launch as “overblown.” He told investors that an influx of AI-generated content could actually boost distribution value — a trend that might help ad platforms, not hurt them. TipRanks

Deutsche Bank echoed this view earlier this week, noting that AppLovin’s risk-reward profile had “meaningfully improved” following the selloff triggered by Genie. The bank said it’s still “far too early” to tell how disruptive the tool might be, and laid out scenarios where it could actually boost advertising businesses linked to gaming. Investing.com

Legal chatter is picking up. On Tuesday, Pomerantz LLP announced it’s probing claims for AppLovin investors.

AppLovin provides software that assists app developers in purchasing ads and monetizing users. Its offerings include the MAX platform along with various marketing tools, per the company profile.

The company said it will release its fourth-quarter and full-year 2025 results on Feb. 11 after the U.S. market closes. CEO Adam Foroughi and CFO Matthew Stumpf are set to lead a webcast that day.

The selloff highlights just how fast sentiment can turn if investors start doubting the “ad stack”—the software chain behind ad auctions and targeting—will hold its value. Should marketers and app developers shift to cheaper, AI-powered platforms sooner than anticipated, AppLovin might see pressure on both pricing and growth.

Next up is the Feb. 11 report. Traders will be watching closely for management’s take on competitive pressures, ad-demand patterns, and whether the company’s edge still hinges on technology or if it’s merely riding the cycle.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • Neurocrine Biosciences (NBIX) Stock Fair Value and Performance in Focus
    July 19, 2026, 3:59 PM EDT. Neurocrine Biosciences (NBIX) is viewed as near fairly valued, with shares trading at a P/E ratio of 25.7x versus a fair value estimate of 26.0x. The stock has increased 73.4% over five years and posted a 29.4% gain in the past year, though this trails some competitors. Valuation signals are mixed, with about half indicating the stock could be expensive. Investors are assessing the resilience of cash flows from current therapies alongside operational risks. Growth prospects are supported by a broad pipeline, including late-stage assets and early commercial progress, yet policy changes and concentration risks are present. The overall assessment shows a valuation that reflects tempered expectations for Neurocrine's earnings potential and profitability.
Bitcoin price today: BTC slides below $76,000 as liquidations and Fed bets jolt crypto
Previous Story

Bitcoin price today: BTC slides below $76,000 as liquidations and Fed bets jolt crypto

BCE’s 2026 playbook: Crave hits 4.6 million subs as Bell posts $594 million Q4 profit
Next Story

BCE’s 2026 playbook: Crave hits 4.6 million subs as Bell posts $594 million Q4 profit

Go toTop